A comprehensive molecular docking-based study to identify potential drug-candidates against the novel and emerging severe fever with thrombocytopenia syndrome virus (SFTSV) by targeting the nucleoprotein
Crossref DOI link: https://doi.org/10.1007/s13237-024-00495-1
Published Online: 2024-05-22
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sengupta, Sutirtha
Mohanty, Sweta
Rababi, Deblina
Nag, Anish http://orcid.org/0000-0001-9435-3795
Text and Data Mining valid from 2024-05-22
Version of Record valid from 2024-05-22
Article History
Received: 20 September 2023
Accepted: 5 May 2024
First Online: 22 May 2024
Declarations
:
: Authors declare there is no conflict of interest.
: NA.
: All authors have read the manuscript and consented to publish.